Amiloride Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 5 mg
Reference Brands: Midamor(US)
Category:
Hypertension
Amiloride is a potassium-sparing diuretic that blocks sodium channels in the distal nephron, reducing sodium reabsorption and potassium excretion. It effectively treats hypertension, edema, and heart failure. Benefits include potassium conservation, blood pressure reduction, decreased fluid retention, and improved cardiac function in heart failure patients.
Amiloride tablets is available in Tablets
and strengths such as 5 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Amiloride tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Amiloride tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Amiloride tablets, marketed as Midamor, are approved in the US by the FDA and in the EU via EMA for managing hypertension, edema, and heart failure. Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and manufacturing information, while the EMA ensures regional safety and quality compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence to regional regulations supports timely approval, safe use, and global availability of amiloride tablets, helping optimize treatment outcomes for potassium-sparing diuretic therapy worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing